Daniel Solomon


Brigham pic Daniel Solomon

Dr. Solomon is a population scientist focusing on the epidemiology and health services of rheumatic disease.  He is a Professor of Medicine at Harvard Medical School and serves as the Chief of the Section of Clinical Sciences in the Division of Rheumatology at Brigham and Women’s Hospital.  His research work is primarily funded by the NIH, AHRQ, and foundations.  He has served major roles at the American College of Rheumatology and within the osteoporosis community as well.  Currently, Dr. Solomon spends the majority of his time on research and mentoring junior investigators, as well as on clinical care.  His teaching is primarily through his research mentoring, but he also precepts in Rheumatology clinic and attends on the Rheumatology consult service. He is also is Co-Director of the Brigham Center for Patient-centered Comparative Effectiveness Research and serves on several NIH and FDA Advisory Panels.

His achievements in population science research focuses on three areas: disparities, analgesic safety and standards of care in osteoporosis.

He has defined the disparity in prescribing for rheumatoid arthritis. Funded through foundation and NIH grants, he has studied why certain patients with rheumatoid arthritis do not receive appropriate care. This work has focused on disparities in care and differences across delivery systems.